Aspen Pharmacare publishes audited annual financial statements for FY2026

• Aspen Pharmacare published audited annual financial statements for fiscal 2026, with no changes to results released Sept. 2, 2026.
• Ernst & Young issued an unmodified audit opinion.
• AGM scheduled for Dec. 3, 2026 at 10:00; voting record date Nov. 27, 2026; last day to trade Nov. 24, 2026.
• Document: https://senspdf.jse.co.za/documents/2026/jse/isse/APN/AFS26.pdf

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspen Pharmacare Holdings Ltd. published the original content used to generate this news brief via SENS, the regulatory disclosure system operated by the Johannesburg Securities Exchange (JSE) (Ref. ID: S604231), on October 02, 2026, and is solely responsible for the information contained therein.